Table 1. Mutational status of KRAS and BRAF genes and p-ERK1/2 expression in ovarian cancer.

Case no.	Histology	Grade	KRAS	BRAF	p-ERK1/2
1	Serous	1	WT	WT	N
2	Serous	1	WT	T1796A/ V600E	P
3	Serous	2	WT	WT	N
4	Serous	3	WT	WT	N
5	Serous	3	WT	WT	N
6	Serous	2	WT	WT	P
7	Serous	2	WT	WT	N
8	Serous	2	WT	WT	P
9	Serous	3	WT	WT	N
10	Serous	3	WT	WT	P
11	Serous	3	WT	WT	P
12	Serous	3	WT	WT	N
13	Serous	3	WT	WT	N
14	Serous	3	G35T/ G12V	WT	P
15	Serous	3	WT	WT	N
16	Serous	3	WT	WT	N
17	Serous	3	WT	WT	N
18	Serous	3	WT	WT	P
19	Serous	3	WT	WT	N
20	Serous	3	WT	WT	N
21	Serous	3	WT	WT	N
22	Serous	3	WT	WT	P
23	Serous	3	WT	WT	P
24	Serous	3	WT	WT	N
25	Serous	3	WT	WT	N
26	Serous	3	WT	WT	P
27	Serous	3	WT	WT	P
28	Mucinous	1	WT	T1796A/ V600E	P
29	Mucinous	1	G35A/ G12D	T1796A/ V600E	P
30	Mucinous	1	WT	WT	N
31	Mucinous	1	WT	T1796A/ V600E	P
32	Mucinous	1	G35T/ G12V	WT	P
33	Mucinous	2	WT	WT	N
34	Mucinous	2	WT	WT	N
35	Mucinous	2	G35A/ G12D	WT	P
36	Mucinous	2	WT	WT	N
37	Mucinous	2	WT	WT	N
38	Mucinous	2	WT	WT	N
39	Mucinous	2	WT	WT	N
40	Mucinous	2	WT	WT	P
41	Mucinous	3	WT	WT	P
42	Mucinous	3	WT	WT	N
43	Mucinous	3	WT	WT	N
44	Mucinous	3	WT	WT	N
45	Mucinous	3	WT	WT	N
46	Mucinous	3	WT	WT	P
47	Mucinous	3	WT	WT	N
48	Endometrioid	1	WT	T1796A/ V600E	P
49	Endometrioid	1	WT	WT	N
50	Endometrioid	2	WT	WT	P
51	Endometrioid	2	WT	WT	N
52	Endometrioid	2	G35A/ G12D	WT	P
53	Endometrioid	2	G35A/ G12D	WT	P
54	Endometrioid	2	G35T/G12V	WT	P
55	Endometrioid	3	G35A/G12D	WT	P
56	Endometrioid	3	WT	WT	N
57	Endometrioid	3	WT	WT	P
58	Endometrioid	3	WT	WT	N

N=negative; P=positive; WT=wild type.